1. Home
  2. EVTC vs HROW Comparison

EVTC vs HROW Comparison

Compare EVTC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$26.42

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$43.13

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
HROW
Founded
1988
1998
Country
United States
United States
Employees
N/A
373
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
EVTC
HROW
Price
$26.42
$43.13
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$35.80
$69.86
AVG Volume (30 Days)
760.3K
790.1K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
N/A
EPS
0.38
N/A
Revenue
$453,869,000.00
N/A
Revenue This Year
$12.68
$31.62
Revenue Next Year
$6.86
$50.77
P/E Ratio
$67.08
N/A
Revenue Growth
11.48
N/A
52 Week Low
$21.81
$28.54
52 Week High
$37.79
$54.98

Technical Indicators

Market Signals
Indicator
EVTC
HROW
Relative Strength Index (RSI) 57.36 71.01
Support Level $25.39 $40.61
Resistance Level $30.05 $51.01
Average True Range (ATR) 1.21 2.11
MACD 0.30 0.96
Stochastic Oscillator 72.31 88.14

Price Performance

Historical Comparison
EVTC
HROW

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: